Frequency of Maintenance Hemodialysis Patients Meeting K/DOQI Criteria for Serum Calcium, Phosphorus, Calcium Phosphorus Product and PTH Levels; a Single Institutional Experience from Pakistan: a Cross Sectional Study

Overview

Journal Pan Afr Med J

Date 2019 Oct 1

PMID 31565143

Citations 4

Authors

Taimoor Khalid Janjua

Kunwer Naveed Mukhtar

Ahmed Kunwer Naveed

Erum Bashir Ahmed

Muhammad Rehan

Affiliations

Soon will be listed here.

Abstract

Introduction: There is a great scarcity of literature in Pakistan investigating the proportion of end stage renal disease (ESRD) patients undergoing hemodialysis (HD) who meet the recommended kidney diseases outcome quality initiative (K/DOQI) guidelines for serum calcium (Ca), phosphorus (P), calcium phosphorus product (Ca x P) and parathyroid hormone (PTH) levels. Our study aimed to determine frequencies of patients who met the K/DOQI targets for these minerals at a tertiary care hospital's dialysis unit.

Methods: 111 ESRD patients on maintenance HD were selected from a tertiary care hospital. Serum Ca and P were assayed on chemistry analyser. PTH was measured through electrochemiluminescence sandwich method. Data were compared with K/DOQI targets and analysed using SPSS-21.

Results: The mean age of patients was 55.85 years (SD ± 13.95). Gender distribution was almost equal with 49.5% males and 50.5% females. The patients had mean corrected serum Calcium 9.12 ± 0.64 mg/dL, Phosphorus 4.57 ± 1.54 mg/dL and Parathyroid hormone 333.8 ± 278.4 pg/mL. The patients had achieved K/DOQI target ranges of Ca, P, PTH, Ca x P product and all 4 criteria in 63.1%, 47.6%, 38.7%, 84.7% and 10.8% respectively.

Conclusion: Majority of patients on maintenance HD at our institution did not achieve the recommended K/DOQI target ranges. Further studies pertaining to the Asian subcontinent will prove resourceful for comparison of mineral metabolism and dialysis outcome of ESRD patients.

Citing Articles

Influence of the Workload and Years of Experience of Nurses on Hemodialysis Quality Using Korean National Hemodialysis Adequacy Evaluation Data.

Kim Y, Lee K Inquiry. 2022; 59:469580221087887.

PMID: 35404165 PMC: 9006365. DOI: 10.1177/00469580221087887.

Comparison between different methods of calculating Kt/V as the marker of adequacy of dialysis.

Fazl-E-Mateen , Ahmad S, Elahi I, Anees M Pak J Med Sci. 2022; 38(1):167-171.

PMID: 35035420 PMC: 8713208. DOI: 10.12669/pjms.38.1.4281.

The optimal range of serum intact parathyroid hormone for a lower risk of mortality in the incident hemodialysis patients.

Zhou X, Guo Y, Luo Y Ren Fail. 2021; 43(1):599-605.

PMID: 33781171 PMC: 8018348. DOI: 10.1080/0886022X.2021.1903927.

Agreement Between Two Nutritional Assessment Scores as Markers of Malnutrition in Patients with End-stage Renal Disease.

Arshad A, Jamal S, Amanullah K Cureus. 2020; 12(3):e7429.

PMID: 32351809 PMC: 7186093. DOI: 10.7759/cureus.7429.

References

Maduell F, Gorriz J, Pallardo L, Pons R, Santiago C . Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia. J Nephrol. 2005; 18(6):739-48. View

. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-201. View

Young E, Akiba T, Albert J, McCarthy J, Kerr P, Mendelssohn D . Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004; 44(5 Suppl 2):34-8. DOI: 10.1053/j.ajkd.2004.08.009. View

Khan D, Fatima-Tuz-Zuhra , Khan F, Saif I . Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi. J Pak Med Assoc. 2009; 59(2):64-7. View

Benabdellah N, Karimi I, Bentata Y, Yacoubi H, Haddiya I . [Phospho-calcic status in chronic hemodialysis in Oriental Morocco: assessment of adherence to K/DOQI and KDIGO recommendations]. Pan Afr Med J. 2014; 16:23. PMC: 3932125. DOI: 10.11604/pamj.2013.16.23.1959. View

Bourguignon C, Dupuy A, Coste T, Michel F, Cristol J . Evaluation of NM-BAPTA method for plasma total calcium measurement on Cobas 8000®. Clin Biochem. 2014; 47(7-8):636-9. DOI: 10.1016/j.clinbiochem.2013.12.027. View

Lebner A, Beard K, Soroka S, Cournoyer S, da Roza G, Geary D . Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada. Nephrol Dial Transplant. 2010; 26(1):156-63. DOI: 10.1093/ndt/gfq459. View

Rivera F, Sanchez de la Nieta M, Echarri R, Anaya S, Carreno A, Vozmediano M . [CA-P control in haemodialysis and K/DOQI guidelines]. Nefrologia. 2006; 26(3):351-7. View

Kimata N, Albert J, Akiba T, Yamazaki S, Kawaguchi T, Kawaguchi Y . Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int. 2007; 11(3):340-8. DOI: 10.1111/j.1542-4758.2007.00190.x. View

10.

Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M . Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism. Ther Apher Dial. 2011; 15 Suppl 1:56-61. DOI: 10.1111/j.1744-9987.2011.00928.x. View

11.

Ho L, Sprague S . Renal osteodystrophy in chronic renal failure. Semin Nephrol. 2002; 22(6):488-93. DOI: 10.1053/snep.2002.35965. View

12.

Drueke T . [The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)]. Nephrol Ther. 2010; 6(3):149-50. DOI: 10.1016/j.nephro.2010.01.001. View

13.

Levey A, Atkins R, Coresh J, Cohen E, Collins A, Eckardt K . Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72(3):247-59. DOI: 10.1038/sj.ki.5002343. View

14.

Imran S, Sheikh A, Saeed Z, Khan S, Malik A, Patel J . Burden of chronic kidney disease in an urban city of Pakistan, a cross-sectional study. J Pak Med Assoc. 2015; 65(4):366-9. View

15.

Kim G, Choi B, Cha D, Chee D, Hwang E, Kim H . Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea. Kidney Res Clin Pract. 2016; 33(1):52-7. PMC: 4714160. DOI: 10.1016/j.krcp.2013.12.003. View

16.

Djukanovic L, Dimkovic N, Marinkovic J, Djuric Z, Knezevic V, Lazarevic T . Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism. Nephron. 2016; 132(3):168-74. DOI: 10.1159/000443848. View

17.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B . Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888):260-72. DOI: 10.1016/S0140-6736(13)60687-X. View

18.

Doumas B, Watson W, BIGGS H . Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971; 31(1):87-96. DOI: 10.1016/0009-8981(71)90365-2. View

19.

Couser W, Remuzzi G, Mendis S, Tonelli M . The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011; 80(12):1258-70. DOI: 10.1038/ki.2011.368. View

20.

Wetmore J, Collins A . Meeting the World's Need for Maintenance Dialysis. J Am Soc Nephrol. 2015; 26(11):2601-3. PMC: 4625689. DOI: 10.1681/ASN.2015060660. View